IL95723A - Method for preparing a solution of an antibody-tagged segment and a kit for radioactive tagging of an antibody segment - Google Patents

Method for preparing a solution of an antibody-tagged segment and a kit for radioactive tagging of an antibody segment

Info

Publication number
IL95723A
IL95723A IL9572390A IL9572390A IL95723A IL 95723 A IL95723 A IL 95723A IL 9572390 A IL9572390 A IL 9572390A IL 9572390 A IL9572390 A IL 9572390A IL 95723 A IL95723 A IL 95723A
Authority
IL
Israel
Prior art keywords
antibody fragment
sterile
solution
stannous chloride
fab
Prior art date
Application number
IL9572390A
Other languages
English (en)
Hebrew (he)
Other versions
IL95723A0 (en
Original Assignee
Immunomedics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Immunomedics Inc filed Critical Immunomedics Inc
Publication of IL95723A0 publication Critical patent/IL95723A0/xx
Publication of IL95723A publication Critical patent/IL95723A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A61K51/10—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A61K51/10—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody
    • A61K51/1045—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody against animal or human tumor cells or tumor cell determinants
    • A61K51/1048—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody against animal or human tumor cells or tumor cell determinants the tumor cell determinant being a carcino embryonic antigen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/12—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules
    • A61K51/1282—Devices used in vivo and carrying the radioactive therapeutic or diagnostic agent, therapeutic or in vivo diagnostic kits, stents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2123/00—Preparations for testing in vivo

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Optics & Photonics (AREA)
  • Public Health (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Immunology (AREA)
  • Cell Biology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Dispersion Chemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
IL9572390A 1989-09-18 1990-09-18 Method for preparing a solution of an antibody-tagged segment and a kit for radioactive tagging of an antibody segment IL95723A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US40824189A 1989-09-18 1989-09-18

Publications (2)

Publication Number Publication Date
IL95723A0 IL95723A0 (en) 1991-06-30
IL95723A true IL95723A (en) 1995-08-31

Family

ID=23615452

Family Applications (1)

Application Number Title Priority Date Filing Date
IL9572390A IL95723A (en) 1989-09-18 1990-09-18 Method for preparing a solution of an antibody-tagged segment and a kit for radioactive tagging of an antibody segment

Country Status (15)

Country Link
EP (1) EP0419203B1 (fi)
JP (1) JPH0723326B2 (fi)
KR (1) KR960015611B1 (fi)
AT (1) ATE110281T1 (fi)
AU (1) AU640698B2 (fi)
CA (1) CA1340250C (fi)
DE (1) DE69011789T2 (fi)
DK (1) DK0419203T3 (fi)
ES (1) ES2063286T3 (fi)
FI (1) FI921146A0 (fi)
IE (1) IE64399B1 (fi)
IL (1) IL95723A (fi)
NO (1) NO920853D0 (fi)
WO (1) WO1991004056A1 (fi)
ZA (1) ZA907420B (fi)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5346687A (en) * 1989-08-09 1994-09-13 Rhomed Incorporated Direct radiolabeling of antibody against stage specific embryonic antigen for diagnostic imaging
US5460785A (en) * 1989-08-09 1995-10-24 Rhomed Incorporated Direct labeling of antibodies and other protein with metal ions
US5443816A (en) * 1990-08-08 1995-08-22 Rhomed Incorporated Peptide-metal ion pharmaceutical preparation and method
ES2098382T3 (es) * 1991-02-05 1997-05-01 Cis Bio Int Procedimiento para la preparacion de una sustancia organoespecifica marcada con tecnecio-99m.
AU658403B2 (en) * 1991-02-27 1995-04-13 Akzo N.V. Technetium-99m labeling of proteins
ZA955642B (en) * 1994-07-07 1997-05-06 Ortho Pharma Corp Lyophilized imaging agent formulation
US5942210A (en) * 1994-11-15 1999-08-24 Cytogen Corporation Methods for lyoprotecting a macromolecule using tricine
US6080384A (en) * 1997-03-25 2000-06-27 American Biogenetic Sciences, Inc. Methods for radionuclide-labeling of biomolecules and kits utilizing the same
CA2302837A1 (en) * 1997-09-08 1999-03-18 The General Hospital Corporation Imaging agents for early detection and monitoring of cardiovascular plaque
US7060251B1 (en) 1997-09-08 2006-06-13 The General Hospital Corporation Imaging agents for early detection and monitoring of cardiovascular plaque
EP1419786A1 (en) * 2002-11-13 2004-05-19 Bracco Imaging S.p.A. Method for the selective and quantitative functionalization of immunoglobulin fab fragments, conjugate compounds obtained with the same and compositions thereof
ITMI20022411A1 (it) * 2002-11-14 2004-05-15 Bracco Imaging Spa Agenti per la diagnosi e la terapia di tumori che espongono sulla superficie delle cellule proteine alterate.
JP2008503493A (ja) * 2004-06-17 2008-02-07 アナザオヘルス コーポレーション 腫瘍を破壊するための安定化され凍結乾燥された放射性薬剤
US7229603B2 (en) * 2004-06-17 2007-06-12 Anazaohealth Corporation Stablilized and lyophilized radiopharmaceutical agents
US20080193379A1 (en) * 2005-06-14 2008-08-14 Nihon Medi-Physics Co., Ltd. Radioactive Diagnostic Imaging Agent

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3725295A (en) * 1971-07-20 1973-04-03 Atomic Energy Commission Technetium labeling
US4057617A (en) * 1975-05-15 1977-11-08 Abramovici J Method of labeling proteins with technetium
US4062933A (en) * 1975-05-27 1977-12-13 Mallinckrodt, Inc. Colloidal compositions with protective agents suitable for radioactive labeling
US4323546A (en) * 1978-05-22 1982-04-06 Nuc Med Inc. Method and composition for cancer detection in humans
US4293537A (en) * 1978-09-05 1981-10-06 Wong Dennis W Novel chemical method of labeling proteins with 99m Tc-Technetium at physiological condition
US4472371A (en) * 1979-10-29 1984-09-18 Summa Medical Corporation Radiolabeled antibody to anti-tumor associated antigen and process
USRE32417E (en) * 1979-10-29 1987-05-12 Summa Medical Corporation Radiolabeled antibody to anti-tumor associated antigen and process
US4311688A (en) * 1979-10-29 1982-01-19 Serono Laboratories Inc. Composition and method for cancer detection in humans
US4401647A (en) * 1980-03-03 1983-08-30 The Regents Of The University Of Ca Radiolabeled neoglycopeptides
US4500507A (en) * 1981-10-30 1985-02-19 Wong Dennis W Diagnostic composition for radiologic imaging of neoplasms in the body and method of preparation
JPS5967228A (ja) * 1982-10-07 1984-04-16 Green Cross Corp:The 寒冷不溶性グロブリンの凍結乾燥方法
US4877868A (en) * 1986-03-12 1989-10-31 Neorx Corporation Radionuclide antibody coupling
EP0354923B1 (en) * 1987-04-02 1994-06-29 Centocor, Inc. Method for labelling antibodies with a metal ion
US5061641A (en) * 1988-04-01 1991-10-29 Immunomedics, Inc. Method for radiolabeling proteins

Also Published As

Publication number Publication date
NO920853L (no) 1992-03-04
DE69011789T2 (de) 1994-12-15
WO1991004056A1 (en) 1991-04-04
AU640698B2 (en) 1993-09-02
DK0419203T3 (da) 1994-12-05
KR920703111A (ko) 1992-12-17
ZA907420B (en) 1991-07-31
FI921146A (fi) 1992-03-17
JPH0723326B2 (ja) 1995-03-15
IE64399B1 (en) 1995-08-09
FI921146A0 (fi) 1992-03-17
AU6521490A (en) 1991-04-18
JPH04505455A (ja) 1992-09-24
CA1340250C (en) 1998-12-15
IL95723A0 (en) 1991-06-30
IE903360A1 (en) 1991-04-10
DE69011789D1 (de) 1994-09-29
ES2063286T3 (es) 1995-01-01
EP0419203A1 (en) 1991-03-27
NO920853D0 (no) 1992-03-04
EP0419203B1 (en) 1994-08-24
ATE110281T1 (de) 1994-09-15
KR960015611B1 (ko) 1996-11-18

Similar Documents

Publication Publication Date Title
US5328679A (en) Methods for technetium/rhenium labeling of proteins
US5061641A (en) Method for radiolabeling proteins
EP0354923B1 (en) Method for labelling antibodies with a metal ion
US5772981A (en) Thiolation of proteins for radionuclide-based radioimmunodetection and radioimmunotherapy
IL94690A (en) Method and kit for radiolabeling antibody fragments using technetium or a radioisotope of rhenium
EP0419203B1 (en) Method for rapidly radiolabelling monovalent antibody fragments with technetium
JP2000053590A (ja) テクネチウムまたはレニウムでの抗体または他のタンパク質の直接放射能標識
US5334708A (en) Method for radiolabeling monovalent antibody fragments
US5746996A (en) Thiolation of peptides for radionuclide-based radiodetection and radiotherapy
EP0831936B1 (en) Thiolation of peptides for radionuclide-based radiodetection and radiotherapy
IL113168A (en) Method and kit for radiolabeling a protein using a radioisotope of rhenium

Legal Events

Date Code Title Description
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees